Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
calcium 667 mg gel |
Is a |
antidot til flussyreforbrænding |
false |
Inferred relationship |
Some |
|
|
calcium 667 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Calcium |
false |
Inferred relationship |
Some |
|
|
calcium 667 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antidote (substance) |
false |
Inferred relationship |
Some |
|
|
calcium 667 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chelating agent |
false |
Inferred relationship |
Some |
|
|
calcium 667 mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrofluoric acid burn antidote (substance) |
false |
Inferred relationship |
Some |
|
|
calcium 667 mg gel |
Has manufactured dose form |
kutan OG/ELLER transdermal doseringsform |
false |
Inferred relationship |
Some |
|
|
calcium 667 mg gel |
Has manufactured dose form |
A semi-solid dose form consisting of a hydrophilic gel. |
false |
Inferred relationship |
Some |
|
|